. 2022 May 10;49(11):3852–3869. doi: 10.1007/s00259-022-05817-6

Table 1.

Examples of injected activity and effective dose for each tracer

Age	Weight* (kg)	D/A (mGy/MBq) Urinary Bladder Wall**				E/A (mSv/MBq)(ICRP, 2015. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. ICRP Publication 128. Ann. ICRP 44(2S). n.d.)				A (MBq)				E(mSv)
Age	Weight* (kg)	[¹⁸F]FDG	[¹⁸F]FET	[¹⁸F]DOPA	[¹¹C]MET	[¹⁸F]FDG	[¹⁸F]FET	[¹⁸F]DOPA	[¹¹C]MET	[¹⁸F]FDG [52]	[¹⁸F]FET [74]	[¹⁸F]DOPA [27]	[¹¹C]MET [52, 90]	[¹⁸F]FDG	[¹⁸F]FET	[¹⁸F]DOPA	[¹¹C]MET
1 y	9.7	4.7E-01	3.0E-01	1.0E + 00	5.1E-01	9.5E-02	8.2E-02	1.0E-01	4.7E-02	2.1–3.0 MBq/kg	3.0 MBq/kg	4 MBq/kg	5.5 MBq/kg	1.9–2.8	2.4	3.9	2.5
5 y	19.8	3.4E-01	2.2E-01	7.8E-01	2.8E-01	5.6E-02	4.7E-02	7.0E-02	2.5E-02					2.3–3.3	2.8	5.5	2.7
10 y	33.2	2.5E-01	1.6E-01	5.7E-01	1.8E-01	3.7E-02	3.1E-02	4.9E-02	1.6E-02					2.6–3.7	3.1	6.5	2.9
15 y	56.8	1.6E-01	1.1E-01	3.8E-01	1.2E-01	2.4E-02	2.1E-02	3.2E-02	1.1E-02					2.9–4.1	3.6	7.3	3.4

^*(ICRP, 2015. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. ICRP Publication 128. Ann. ICRP 44(2S). n.d.)

^**Critical organ

D/A absorbed dose per activity administered, E/A effective dose per activity administered